Companies: 10,795·Total market cap: $144.5T
Prime Medicine, Inc.

Prime Medicine, Inc.

PRMENASDAQHealthcare● Active
$2.99
$-0.07(-2.29%)
Market Cap$540028114
P/E Ratio
52W High$6.94
52W Low$1.305
Overview

Prime Medicine, Inc. (PRME) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PRME · as of Jun 8, 2026

Activity summary

Buy transactions

11

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Prime Medicine, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PRME insider buying and selling by quarter

PRME insider selling · PRME insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
12.7M6.3M0
2025 Q2
2025 Q3
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PRME ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PRME executive sell shares · PRME board member insider trading · PRME insider trading SEC filing

Showing 13 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

GV 2021 GP, L.L.C.

10 percent owner

Purchase

Date

Aug 1

Shares

1,500,000

Price

$3.30

Value

$4.95M ⚡

View Form 4 on SEC.gov

NELSEN ROBERT

Director

Purchase

Date

Aug 1

Shares

3,030,300

Price

$3.30

Value

$10.00M ⚡

View Form 4 on SEC.gov

ARCH Venture Partners XII, LLC

10 percent owner

Purchase

Date

Aug 1

Shares

3,030,300

Price

$3.30

Value

$10.00M ⚡

View Form 4 on SEC.gov

ARCH Venture Partners X, LLC

10 percent owner

Purchase

Date

Aug 1

Shares

3,030,300

Price

$3.30

Value

$10.00M ⚡

View Form 4 on SEC.gov

Liu David R.

10 percent owner

Purchase

Date

Jun 30

Shares

21,000

Price

$2.52

Value

$53K

View Form 4 on SEC.gov

Liu David R.

10 percent owner

Purchase

Date

Jun 23

Shares

21,000

Price

$2.16

Value

$45K

View Form 4 on SEC.gov

Liu David R.

10 percent owner

Purchase

Date

Jun 16

Shares

21,000

Price

$1.49

Value

$31K

View Form 4 on SEC.gov

Liu David R.

10 percent owner

Purchase

Date

Jun 11

Shares

21,000

Price

$1.60

Value

$34K

View Form 4 on SEC.gov

Brudnick Richard

Chief Business Officer

Purchase

Date

May 20

Shares

20,000

Price

$1.19

Value

$24K

View Form 4 on SEC.gov

LEE ANN L.

Chief Technical Officer

Purchase

Date

May 21

Shares

100,000

Price

$1.13

Value

$113K

View Form 4 on SEC.gov

Reine Allan

CEO · Director

Purchase

Date

May 21

Shares

125,000

Price

$1.18

Value

$147K

View Form 4 on SEC.gov

Gottesdiener Keith Michael

See Remarks · Director

Gift

Date

Oct 8

Shares

226,925

Price

Value

View Form 4 on SEC.gov

Gottesdiener Keith Michael

See Remarks · Director

Gift

Date

Oct 8

Shares

226,925

Price

Value

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PRME insider trading

PRME insider trades

Prime Medicine, Inc. (PRME) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Liu David R. (10 percent owner), GV 2021 GP, L.L.C. (10 percent owner), NELSEN ROBERT (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. PRME insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Prime Medicine, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PRME insider trading · 5 questions

The insiders of Prime Medicine, Inc. (PRME) include executives and directors such as Liu David R. (10 percent owner), GV 2021 GP, L.L.C. (10 percent owner), NELSEN ROBERT (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PRME board member insider tradingwho are PRME insidersPRME insider rosterPrime Medicine, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026